Overview


According to FutureWise analysis, the market for Tissue and Organ Transplantation is expected to grow with a CAGR of 9.1% over the forecast period 2024-2032, and reach a market value of US$ 36.2 Billion by 2031. 

Tissue and organ transplantation represents a critical medical intervention for individuals suffering from organ failure, severe tissue damage, or certain genetic disorders. This life-saving procedure involves the removal of a healthy organ or tissue from a donor, living or deceased, and its surgical placement into a recipient whose organ function has been compromised. The success of a transplant hinges on several factors, including donor compatibility, the careful preservation of the organ, and the suppression of the recipient's immune response to prevent rejection. The field of transplantation has seen remarkable progress due to advancements in surgical interventions, immunosuppressive medications, and a deepening understanding of immunology.

Commonly transplanted organs include the heart, kidneys, liver, lungs, and pancreas. Additionally, tissues such as corneas, bone marrow, skin, and blood vessels are frequently transplanted. In some cases, composite tissue transplantation, involving multiple types of tissues (such as face and hand transplants), has emerged as a groundbreaking area of transplantation medicine. Immunosuppressive medications play a crucial role in transplantation by inhibiting the recipient's immune system from identifying the transplanted organ as foreign and initiating an immune response. Achieving the proper equilibrium between dampening the immune reaction and maintaining its capacity to protect against infections is a sensitive task, necessitating meticulous observation and fine-tuning.

FutureWise Market Research has published a report that provides an insightful analysis of Tissue and Organ Transplantation Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Tissue and Organ Transplantation Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Zimmer Biomet,
  • Medtronic PLC,
  • Teva Pharmaceuticals,
  • Veloxis Pharmaceutical.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Tissue and Organ Transplantation Market:

  • In July of 2022, Carl Zeiss Meditec joined forces with Precise Bio to collaboratively advance and bring to market engineered corneal tissue. This development is aimed at benefiting patients in need of endothelial keratoplasty and natural lenticular transplants, particularly for addressing conditions like keratoconus and facilitating vision correction.
  • In March of 2022, Zimmer Biomet established a multi-year partnership with Biocomposites. This agreement grants Zimmer Biomet exclusive distribution rights for the Genex Bone Graft Substitute, coupled with its innovative mixing system and diverse delivery options, specifically within the United States.

Continuous advancements in surgical procedures and techniques have significantly improved tissue and organ transplantation's success rate, driving the market. Minimally invasive techniques and precision instruments have made surgeries safer and more efficient. The development of advanced organ preservation solutions and techniques, such as hypothermic perfusion and normothermic machine perfusion, has extended the viability of organs, increased the likelihood of successful transplantation and boosted market growth. The rising incidence of organ failure due to age-related degeneration, chronic diseases, and lifestyle-related conditions drives the demand for organ transplantation. This trend is expected to continue with an aging population. Increasing awareness campaigns and supportive government policies and initiatives have led to a greater acceptance of organ donation and created new opportunities for market growth.

However, the demand for organs far outweighs the available supply. Shortages are particularly acute for organs like hearts, lungs, and livers. This leads to long waiting lists for transplant candidates, and unfortunately, not all patients receive the transplants they need in time, thus restraining the market growth. Long-term use of immunosuppressive drugs can exhibit various complications, including increased susceptibility to infections, metabolic disorders, and kidney dysfunction. Balancing immunosuppression to prevent rejection while minimizing side effects is challenging for market growth.

By Product Type

  • Tissue Products,
  • Preservation Solution,
  • Immunosuppressive Drugs.

By Application

  • Organ Transplantation
  • Tissue Transplantation

By End User

  • Hospital,
  • Transplant Centers,
  • Others.

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the high prevalence of organ failures of patients, the presence of established healthcare infrastructure and advanced transplant centers in the U.S., and the consistent development of healthcare infrastructure within the region. Conversely, the Asia-Pacific region is poised for substantial expansion in the forecast period due to the high prevalence of organ failures in patients and the consistent development of healthcare infrastructure.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Tissue and Organ Transplantation Market By Product Type, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Tissue and Organ Transplantation Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Tissue and Organ Transplantation Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Tissue and Organ Transplantation Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Tissue and Organ Transplantation Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Tissue Products
        2. Preservation Solution
        3. Immunosuppressive Drugs.

  • 8.  Tissue and Organ Transplantation Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Organ Transplantation
        2. Tissue Transplantation.

  • 9.  Tissue and Organ Transplantation Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Hospital
        2. Transplant Centers
        3. Others.

  • 10.  North America Tissue and Organ Transplantation Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.  Latin America Tissue and Organ Transplantation Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.  Europe Tissue and Organ Transplantation Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.  Asia Pacific Tissue and Organ Transplantation Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Zimmer Biomet
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Medtronic PLC
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Teva Pharmaceuticals,
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Veloxis Pharmaceutical.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client

    •     


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11